Wade J. Sexton
University of South Florida(US)Moffitt Cancer Center(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Renal cell carcinoma treatment, Urological Disorders and Treatments, Renal and related cancers
Most-Cited Works
- → Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial(2016)631 cited
- → Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology(2020)623 cited
- → Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy(2003)384 cited
- → Bladder Cancer(2013)312 cited
- → NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022(2022)293 cited
- → Pretreatment Total Testosterone Level Predicts Pathological Stage in Patients With Localized Prostate Cancer Treated With Radical Prostatectomy(2003)292 cited